Pharmaceutical

Star Therapeutics raises $90m in funding to advance antibody therapies

The Series C funding will support the clinical advancement of Vega Therapeutics’ antibody candidate for treating von Willebrand disease.

Sep 5, 2023 - 20:00
Star Therapeutics raises $90m in funding to advance antibody therapies
The Series C funding will support the clinical advancement of Vega Therapeutics’ antibody candidate for treating von Willebrand disease.
Read the original article

Tags:

Previous Article

Direct oral anticoagulants’ positive effects on cancer-associated VTE

Next Article

Launching pharmaceuticals in the Nordics: Opportunities and challenges

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Telehealth company Included Health ventures into home care

Telehealth company Included Health ventures into home care

May 17, 2023

New Alzheimer’s disease medication approved in Japan

New Alzheimer’s disease medication approved in Japan

Sep 25, 2023

New England Journal of Medicine reckons with its racist past and complicity in slavery

New England Journal of Medicine reckons with its racist...

Dec 7, 2023